Cargando...
A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone
Improved understanding of the adverse pharmacological properties of aldosterone has prompted investigation of the clinical benefits of blocking aldosterone at the receptor level. This article reviews the pharmacology, clinical efficacy, and tolerability of the two available blocking agents, spironol...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652937/ https://ncbi.nlm.nih.gov/pubmed/18404673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20324 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|